119 related articles for article (PubMed ID: 31878039)
1. Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism
Poupet C; Veisseire P; Bonnet M; Camarès O; Gachinat M; Dausset C; Chassard C; Nivoliez A; Bornes S
Microorganisms; 2019 Dec; 8(1):. PubMed ID: 31878039
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights.
Poupet C; Saraoui T; Veisseire P; Bonnet M; Dausset C; Gachinat M; Camarès O; Chassard C; Nivoliez A; Bornes S
PLoS One; 2019; 14(11):e0216184. PubMed ID: 31693670
[TBL] [Abstract][Full Text] [Related]
3.
Poupet C; Rifa É; Theil S; Bonnet M; Veisseire P; Cardin G; Guéret É; Rialle S; Chassard C; Nivoliez A; Bornes S
Front Microbiol; 2022; 13():1062113. PubMed ID: 36620055
[TBL] [Abstract][Full Text] [Related]
4. Elemental sulfur enhances the anti-fungal effect of Lacticaseibacillus rhamnosus Lcr35.
Kaur M; Miquel S; Ollivier-Nakusi L; Thoral C; Vareille-Delarbre M; Bekirian C; d'Enfert C; Fontaine T; Roget K; Forestier C
Microbes Infect; 2024; 26(3):105286. PubMed ID: 38160785
[TBL] [Abstract][Full Text] [Related]
5. Identification of sulfur components enhancing the anti-Candida effect of Lactobacillus rhamnosus Lcr35.
Dausset C; Bornes S; Miquel S; Kondjoyan N; Angenieux M; Nakusi L; Veisseire P; Alaterre E; Bermúdez-Humarán LG; Langella P; Engel E; Forestier C; Nivoliez A
Sci Rep; 2020 Oct; 10(1):17074. PubMed ID: 33051479
[TBL] [Abstract][Full Text] [Related]
6. Thymol has antifungal activity against Candida albicans during infection and maintains the innate immune response required for function of the p38 MAPK signaling pathway in Caenorhabditis elegans.
Shu C; Sun L; Zhang W
Immunol Res; 2016 Aug; 64(4):1013-24. PubMed ID: 26783030
[TBL] [Abstract][Full Text] [Related]
7. Study of the Lactobacillus rhamnosus Lcr35® properties after compression and proposition of a model to predict tablet stability.
Muller C; Mazel V; Dausset C; Busignies V; Bornes S; Nivoliez A; Tchoreloff P
Eur J Pharm Biopharm; 2014 Nov; 88(3):787-94. PubMed ID: 25128853
[TBL] [Abstract][Full Text] [Related]
8. Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35®.
Nivoliez A; Camares O; Paquet-Gachinat M; Bornes S; Forestier C; Veisseire P
J Biotechnol; 2012 Aug; 160(3-4):236-41. PubMed ID: 22542933
[TBL] [Abstract][Full Text] [Related]
9. Influence of manufacturing processes on cell surface properties of probiotic strain Lactobacillus rhamnosus Lcr35®.
Nivoliez A; Veisseire P; Alaterre E; Dausset C; Baptiste F; Camarès O; Paquet-Gachinat M; Bonnet M; Forestier C; Bornes S
Appl Microbiol Biotechnol; 2015 Jan; 99(1):399-411. PubMed ID: 25280746
[TBL] [Abstract][Full Text] [Related]
10. Comparative phase I randomized open-label pilot clinical trial of Gynophilus
Dausset C; Patrier S; Gajer P; Thoral C; Lenglet Y; Cardot JM; Judlin P; Ravel J; Nivoliez A
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1869-1880. PubMed ID: 30032443
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.
de Sá NP; de Paula LFJ; Lopes LFF; Cruz LIB; Matos TTS; Lino CI; de Oliveira RB; de Souza-Fagundes EM; Fuchs BB; Mylonakis E; Johann S
J Glob Antimicrob Resist; 2018 Sep; 14():287-293. PubMed ID: 29715565
[TBL] [Abstract][Full Text] [Related]
12. Combined Effects of
Kim BG; Kim JN; Jang AS; Shin M
Allergy Asthma Immunol Res; 2020 Jul; 12(4):701-711. PubMed ID: 32400134
[TBL] [Abstract][Full Text] [Related]
13. Cell Signaling of
Zhou M; Liu X; Yu H; Yin X; Nie SP; Xie MY; Chen W; Gong J
Front Immunol; 2018; 9():1745. PubMed ID: 30250464
[TBL] [Abstract][Full Text] [Related]
14. Phagocytes from Mice Lacking the Sts Phosphatases Have an Enhanced Antifungal Response to Candida albicans.
Frank D; Naseem S; Russo GL; Li C; Parashar K; Konopka JB; Carpino N
mBio; 2018 Jul; 9(4):. PubMed ID: 30018105
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of the Non-conventional Caenorhabditis elegans Model to Assess Candida Virulence.
Ortega-Riveros M; De-la-Pinta I; Marcos-Arias C; Ezpeleta G; Quindós G; Eraso E
Mycopathologia; 2017 Oct; 182(9-10):785-795. PubMed ID: 28523422
[TBL] [Abstract][Full Text] [Related]
16. Clinical strains of Lactobacillus reduce the filamentation of Candida albicans and protect Galleria mellonella against experimental candidiasis.
Rossoni RD; Dos Santos Velloso M; Figueiredo LMA; Martins CP; Jorge AOC; Junqueira JC
Folia Microbiol (Praha); 2018 May; 63(3):307-314. PubMed ID: 29170992
[TBL] [Abstract][Full Text] [Related]
17. Culture Supernatants of Lactobacillus gasseri and L. crispatus Inhibit Candida albicans Biofilm Formation and Adhesion to HeLa Cells.
Matsuda Y; Cho O; Sugita T; Ogishima D; Takeda S
Mycopathologia; 2018 Aug; 183(4):691-700. PubMed ID: 29603066
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of probiotic lactobacilli supernatants on single and mixed non-albicans Candida species biofilm.
Tan Y; Leonhard M; Moser D; Ma S; Schneider-Stickler B
Arch Oral Biol; 2018 Jan; 85():40-45. PubMed ID: 29031236
[TBL] [Abstract][Full Text] [Related]
19. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
Sun L; Liao K; Wang D
PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis.
Rossoni RD; de Barros PP; de Alvarenga JA; Ribeiro FC; Velloso MDS; Fuchs BB; Mylonakis E; Jorge AOC; Junqueira JC
Biofouling; 2018 Feb; 34(2):212-225. PubMed ID: 29380647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
